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Abstract:  Objective: The objective of this survey was to assess adult primary care physicians’ and pediatricians’ 
perceptions of asthma exacerbation management, including beliefs concerning the discharge of patients from the 
emergency department (ED) following asthma exacerbations. 
Methods: This was a cross-sectional survey of primary care physicians (PCPs) treating adult or pediatric patients. Surveys 
were mailed to physicians and included questions on how PCPs define an exacerbation, how they are notified and how 
they followed-up with their patients who experienced exacerbations. 
Results: A total of 189 physicians were targeted in this survey, with 124 (65%) returning a completed survey. The 
majority of physicians agreed that an exacerbation included worsening asthma requiring a course of oral corticosteroids 
(83%). However,  70% of physicians agreed that an exacerbation could also include events which did not require OCS. 
Overall, 71% of PCPs believed that the majority of their patients’ asthma exacerbations were treated in the doctor’s office 
with only 6% believing the majority were treated in the ED. Over 90% of PCPs surveyed said they scheduled a follow-up 
with their patients “all or most of the time” when notified of an ED visit for an asthma exacerbation. Of the adult PCPs 
surveyed, 20% said they were never notified when one of their patients received treatment in the hospital because of an 
asthma exacerbation, whereas only 10% of pediatricians said they were never notified. The majority of PCPs surveyed 
(79%) indicated that if a controller medication was warranted, the ED staff should initiate treatment at time of discharge. 
Conclusions: This study showed that healthcare providers may not share a common definition of an asthma exacerbation. 
In addition, most physicians believe that the majority of exacerbations are treated in their office or at home. Further, most 
agreed that if a controller medication was warranted, the ED or urgent care staff should initiate treatment. 
Keywords: Asthma, exacerbations, emergency department, primary care. 
INTRODUCTION 
  Asthma exacerbations are often associated with lack of 
asthma control. They can be severe enough to lead to 
emergency department (ED) visits or hospital admissions, 
and even death [1]. Patients who have exacerbations 
requiring an ED visit, hospitalization, or intensive care unit 
admission are at greater risk of exacerbations in the future. In 
addition, severe asthma exacerbations can occur in patients 
across the spectrum of disease severity including patients 
considered to have “mild” asthma [2-4]. Asthma guidelines 
indicate that disease awareness education, follow-up care 
and assessment of appropriate use of long-term controller 
medications should be priority items in the discharge 
planning of patients from the ED or hospital [1]. In a study 
by Singh and colleagues, 31% of patients overall used the 
ED first when experiencing asthma problems, and 22% 
reported the ED as their usual source of asthma 
prescriptions. Even in patients with a PCP, 10% used the ED 
as their primary provider of asthma medications [5]. 
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Importantly, studies have shown that approximately 70% of 
patients do not receive controller medications, such as 
inhaled corticosteroids, on discharge from the ED [6, 7]. The 
reason for this is not well understood. It may be that ED staff 
focuses solely on treating the current acute event or 
physicians assume patients will receive these medications 
upon follow-up with their PCP. 
  Therefore, we sought to assess adult primary care 
physician and pediatrician perceptions of asthma exacerbat-
ion management, including beliefs concerning the discharge 
of patients from the ED following asthma exacerbations. 
METHODS 
Study Design 
  This was a cross-sectional survey of PCPs, conducted 
from June through August 2008. The final survey was 
approved by the institutional review board of RTI Inter-
national. 
Study Setting and Population 
  Physicians from thirty-five adult primary care and 29 
pediatric study sites focusing on the delivery of health care 
that were currently participating in an ongoing observational 10    The Open Respiratory Medicine Journal, 2010, Volume 4  Lincourt et al. 
study were invited to complete the questionnaire. Sites were 
identified from a proprietary database of more than 2000 US 
physicians with membership in the Primary Care Network, 
an organization that provides continuing medical education 
to its members. Study sites were excluded if they specialized 
in asthma treatment or had an asthma specialist on staff, or if 
they had participated in a respiratory-related clinical research 
study in the previous 3 years. 
Study Protocol and Measurements 
  This survey was administered to physicians as part of the 
the Asthma Control Characteristics and Prevalence Survey 
Studies (ACCESS; ADA111118/19). Although physicians 
from across the country participated in this exacerbation 
survey it was not the intent to get a geographic 
representation or random sample of physician responses and 
we did not stratify results by region or practice dynamics 
(e.g. size of practice). 
  A brief questionnaire was developed by RTI Health 
Solutions in collaboration GlaxoSmithKline, a maker of 
inhaled asthma medications, which included questions on how 
PCPs define and are informed of their patients’ exacerbations, 
and how they followed-up with patients who experienced 
exacerbations. Initially, a pilot survey was conducted to 
cognitively pre-test the questions among physicians (5 PCPs 
and 5 pediatricians) and to identify any revisions necessary to 
maximize understanding and ease of completion of the final 
survey. Based upon feedback from the pilot, modifications 
were made to the final survey instrument. These changes were 
minor and included rewording of several questions to increase 
understanding. The final survey contained a total of 25 
questions, 18 of which dealt with issues related to asthma 
exacerbations (Appendix I) and are described in this report 
Exacerbations in this survey were identified from a spectrum 
of options by the physicians such as the need for 
hospitalization, use of oral corticosteroids, ED visits, increase 
in rescue medication use; or change in controller medication 
without a course of oral corticosteroids. 
Data Analysis 
  Descriptive analysis and tables summarizing survey results 
were produced for the entire sample and also stratified by type 
of PCP (adult or pediatric). For continuous-type data, the mean, 
standard deviation, median, minimum, and maximum were 
generated, whereas counts and percentages were produced for 
categorical data. Data analysis was performed using SAS 
version 9.1.3 (SAS Institute Inc., Cary, NC). 
RESULTS 
  A total of 189 physicians were sent the final survey, with 
124 (65%) returning a completed survey. Among the 124 
respondents, there were 56 adult primary care physicians and 
68 pediatricians. This sample of physicians was 
geographically dispersed across the US (25% Midwest, 22% 
Northeast, 25% South, and 28% West). 
  The majority of physicians agreed that an exacerbation is 
defined as worsening asthma requiring a course of oral 
corticosteroids (83%). However, 70% of physicians agreed 
that an exacerbation could also include events which did not 
require OCS, but rather, resulted in increased use of rescue 
albuterol for two or more consecutive days or required an 
inhaled or nebulized albuterol intervention in the physician’s 
office or prompted the need to change maintenance 
medications (Fig. 1). When asked to rank events most likely 
to trigger an exacerbation, both adult and pediatric PCPs 
ranked poor compliance with asthma medication, common 
cold or flu or allergen exposures the highest. Pediatric PCPs 
were more likely to rank common cold or flu as the primary 
trigger while adult PCPs were more likely to rank poor 
compliance with asthma medication as the primary trigger. 
When asked about which season Adult PCPs see the most 
asthma exacerbations, 45% reported winter, 30% reported 
fall, 23% reported spring, 0% reported summer, and 5% 
reported they do not see any seasonal differences. When 
Pediatricians were asked the same question, 48% reported 
fall, 39% reported winter, 13% reported spring, 0% reported 
summer, and 0% reported they do not see any seasonal 
differences. 
  Overall, 71% of All PCPs believed that the majority of 
their patients’ asthma exacerbations were treated in the 
doctor’s office. Further, 19% believed treatment usually 
occurred in the patient’s home, 6%, the ED, another 4% in 
urgent care, and 3% said they did not know. Approximately 
half of the PCPs (55% of adult PCPs and 43% of 
pediatricians) said they were notified of their patient’s ED 
visit or hospitalization within a few days of the event, 
whereas 27% and 49%, respectively, were notified at the 
time of hospital visit. Only 4% of adult and 10% of pediatric 
PCPs were notified of an urgent care visit at the time of the 
event. Approximately 20% of adult and 10% of pediatric 
PCPs said they are never notified of an ED visit for asthma 
and became of aware of these events later (Table 1). On the 
other hand, results show that a large percentage (40%) of 
adult PCPs said they receive no notification of their patient’s 
visit to an urgent care center for an exacerbation; this 
percentage is less (29%) for pediatric providers. When adult 
PCPs and pediatricians were notified that their patient had 
been treated for an asthma exacerbation in the ED, the 
majority (91%) required a follow-up visit in the office “all of 
the time or most of the time”. In contrast, only 73% stated 
that they followed-up through an in-office visit for patients 
who treated an exacerbation at home. The majority of 
physicians surveyed (79%) indicated that if a controller 
medication was warranted, the ED or urgent care staff should 
initiate treatment at time of discharge. 
Table 1.   How Primary Care Physicians are Notified of ED or 
Hospital Admissions for Asthma Exacerbations 
 
Method of Information*   Adult PCPs  Pediatricians 
Call from the ED  13 (23.2%)  24 (35.3%) 
Note, letter, fax or e-mail  
from the ED 
33 (58.9%)  43 (63.2%) 
Call from hospital or  
attending physician  
3 (5.4%)  20 (29.4%) 
Contact from patient via phone, 
 e-mail or office visit 
17 (30.4%)  33 (48.5%) 
Do not get notified   11 (19.6%)  7 (10.3%) 
Other  0 (0%)  2 (2.9%) 
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DISCUSSION  
  Exacerbations consist of a sustained, often progressive, 
deterioration in asthma symptoms and airflow obstruction 
that occurs over hours to days and can last for days to weeks, 
where additional medications and/or emergency care is often 
needed. These attacks generally allow time for intervention; 
however, a few patients have a rapid onset or a severe 
asthma exacerbation and require immediate medical 
attention [8]. In this survey most PCPs reported that the 
majority of their patient’s asthma exacerbations were treated 
in the doctor’s office. These findings suggest that the 
intensity of the exacerbations could have been perceived as 
not too severe and therefore, required a less aggressive 
intervention. This could be also a function of the 
interpretation or definition of an exacerbation. In 2008 the 
National Health Interview Survey (NHIS) included the 
following question to their asthma prevalence survey, 
“During the past 12 month months, have you had an episode 
of asthma or an asthma attack?” [9]. The use of the term 
“asthma attack” appears to be in recognition of a broader 
definition of exacerbations that may be less severe but still 
clinically important. Considering the significant impact these 
“asthma attacks” have on the patient and the need for a 
clinical response, perhaps the primary care physician’s 
definition is also appropriate with the modifier of mild or 
moderate exacerbation. The burden of uncontrolled asthma 
may be under reported considering that these milder events 
may not be captured in many epidemiological surveys that 
track asthma morbidity. Therefore, a broader, common 
definition of an asthma exacerbation between all health care 
providers may help the precision for reporting serious 
episodes of worsening asthma and in turn, increase quality of 
care for millions of patients with asthma. In addition, 
patients seen in the sites surveyed may have been more 
likely not to use the ED for less severe events or for events 
that occurred during normal office hours. 
  An interesting difference between responses of adult 
PCPs and pediatricians was the season when providers 
observe the greatest number of asthma exacerbations. For 
adult PCPs, the majority reported winter as being the season 
when they observe the most exacerbations in their patient 
population. On the other hand, the majority of pediatricians 
reported fall as the season when they observe the greatest 
number. This difference may in fact relate to the start of 
school in younger asthmatics. 
  PCPs questioned in this survey stated they were usually 
notified within a few days of an ED visit in the majority of 
cases, with pediatricians reporting being notified 90% of the 
time. This number may be an over-estimate since it 
represents only the events the PCP was made aware of at a 
later date. Over 90% of PCPs surveyed said they scheduled a 
follow-up with their patients “all or most of the time” when 
notified of an ED visit for an asthma exacerbation. Also 
evident from the data collected was that PCPs are less aware 
of urgent care visits for asthma than for ED visits or 
hospitalizations. These results highlight the importance of 
having consistent communication to allow follow-up with 
patients in a timely manner and possibly preventing further 
asthma morbidity. 
  The majority of physicians surveyed (79%) indicated 
that, if a controller medication was warranted, the ED or 
urgent care staff should initiate treatment at time of 
discharge. National guidelines for the treatment of asthma 
suggest that sufficient medication be prescribed so that 
patients may continue treatment until follow-up [1]. Despite 
the current evidence supporting the role of anti-inflammatory 
controller agents in the management of chronic asthma, data 
suggest that few ED physicians prescribe these agents at the 
time of discharge, perhaps thinking that the patient’s primary 
care physician will address this at follow-up [10]. However, 
many patients may not see their primary care physician soon 
enough after an exacerbation, and even when they do, many 
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do not receive inhaled corticosteroids. Also, for many 
patients with asthma without a PCP, the ED may be their 
primary source of care [5]. Patients who present to the ED 
with acute asthma are often under-treated prior to the event, 
or are non-adherent to their asthma management plan [5, 6]. 
This was confirmed as most PCPs in our study identified 
poor medication compliance as a significant trigger for 
exacerbations. These patients may benefit from a 
reassessment of their asthma management plan, including 
starting controller therapy, since it has been found that 
inhaled corticosteroids initiated at ED discharge were most 
often continued at follow-up by the primary care physician 
[11]. Knowing that the majority of PCPs felt it was 
acceptable for a controller medication to be initiated in the 
ED may help remove one of the obstacles and perception 
associated with prescribing asthma controller medications at 
discharge. To facilitate continuity of care, ED physicians 
should also consistently provide summaries of care received 
and medications prescribed to the patient’s PCP. 
LIMITATIONS 
  There are some limitations to the present study design 
and survey methodology. The overall sample was 
geographically diverse with a response rate of over 60%, 
however physicians that responded to the survey may not 
have been fully representative of overall PCP population of 
the US Due to the small sample size within each region, we 
were not able to stratify results by region or practice 
dynamics (e.g. size of practice) so it is unknown if any 
differences exist. 
  Another potential limitation is that the survey was 
qualitative in nature and written to elicit opinions of the 
physician based on physician experience and recall. 
Therefore, further studies would need to be conducted to 
quantify these findings. 
CONCLUSIONS 
  This study showed that healthcare providers may not 
share a common definition of an asthma exacerbation.  In 
addition, most physicians believe that the majority of 
exacerbations are treated in their office or at home.  Further, 
most agreed that if a controller medication was warranted, 
the ED or urgent care staff should initiate treatment. 
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APPENDIX 1 
Part II – Asthma Exacerbations  
Questions 6-18 Present Various Scenarios Describing 
Exacerbations in the General Asthma Population 
  Please consider the following examples of controller 
medications when answering questions 6-18.  
￿  Inhaled Corticosteroids: Treat airway inflam-
mation; for example, Flovent (fluticasone 
propionate), QVAR (BDP). Daily long-term oral 
systemic corticosteroid is a controller only in the 
case of severe persistent asthma.  
￿  Inhaled Cromolyn sodium and nedocromil: 
Stabilize mast cells; for example, Tilade 
(nedocromil).  
￿    Immunomodulators: Monoclonal antibody that 
prevents binding of IgE (anti-IgE) to the high-
affinity receptors on basophils and mast cells; for 
example, Xolair (omalizumab).  
￿  Leukotriene modifiers: Include LTRAs and a 5-
lipoxygenase inhibitor; for example, Singulair 
(montelukast), Accolate.  
￿  LABAs: Bronchodilators with duration of effect 
of at least 12 hours; for example, Serevent 
(salmeterol) and Foradil (formoterol). Currently 
recommended in combination with an ICS.  
￿  Methylxanthines: Sustained-release theophylline 
with a mild to moderate bronchodilator effect; for 
example, Theo-Dur, Uniphyl.  
  Note: Reliever medications such as Ventolin (albuterol) 
are not considered controller medications.  
To What Extent Do You Agree that Each Statement 
Below Describes an Asthma Exacerbation? For Each 
Statement, Please Choose One Answer Only 
  6. An exacerbation of asthma has occurred if there are 
significant respiratory symptoms requiring a course of oral 
corticosteroids (OCS) (>5 days) to control symptoms.  
￿  Agree  
￿  Neither agree nor disagree  
￿  Disagree  
  7. An exacerbation of asthma has occurred if significant 
symptoms require any change in asthma controller 
medication (e.g., change to different medication, increase in 
same medication, addition of new controller medication) 
without a course of OCS.  
￿  Agree  
￿  Neither agree nor disagree  
￿  Disagree  
  8. An exacerbation of asthma has occurred if an 
emergency room (ER) visit is required for asthma.  
￿  Agree  
￿  Neither agree nor disagree  
￿  Disagree  
  9. An exacerbation of asthma has occurred if in-patient 
hospitalization is required for asthma.  
￿  Agree  
￿  Neither agree nor disagree  
￿  Disagree  
  10. An exacerbation of asthma has occurred if an office 
visit for inhaled/ nebulized short-acting beta2
 
agonist 
(SABA) treatment is required, without requiring treatment 
with OCS.  
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￿  Neither agree nor disagree  
￿  Disagree  
  11. An exacerbation of asthma has occurred if increasing 
asthma symptoms require increased SABA use (e.g., more 
than 3 to 4 times daily) for 2 or more consecutive days.  
￿  Agree  
￿  Neither agree nor disagree  
￿  Disagree  
  12. In your experience, which of the following events are 
most likely to trigger an asthma exacerbation? Rank each 
event, with 1 being the most common trigger.  
  Poor compliance with asthma therapy  
  Smog or pollution  
  Changes in air temperature or humidity  
  Allergen exposure (all types)  
  Smoking or second hand smoke  
  Common cold or flu (viral infection)  
  Strenuous physical activities  
  Stress  
  Hormonal events (e.g., birth control, menstrual 
cycle)  
  Other, specify: ---------------------------------------- 
  Other, specify: ---------------------------------------- 
  13. During the past 12 months, in what season have you 
observed the greatest number of asthma exacerbations in 
your respiratory patients? Choose one answer only.  
￿  Spring  
￿  Summer  
￿  Fall  
￿  Winter  
￿  No seasonal differences  
  14. In your opinion, where are the majority of your 
patients’ asthma exacerbations treated?  
￿  ER  
￿  Urgent care clinic  
￿  Patient’s home  
￿  Doctor’s office  
￿  Other, specify: ---------------------------  
￿  Don’t know or unable to determine  
  15. When you are notified about a patient’s asthma 
exacerbation that was treated in the ER or hospital, what are 
the typical methods in which you are notified? Check all that 
apply.  
￿  Call from the ER  
￿  Note, letter, fax, or e-mail from the ER  
￿  Call from the hospital or attending physician or 
on-call physician  
￿  Do not usually get notified  
￿  Contact from patient via telephone, e-mail, or 
office visit  
￿  Other, specify: ---------------------------  
  16. When you are notified about a patient’s asthma 
exacerbation that was treated in an urgent care clinic, what 
are the typical methods in which you are notified? Check all 
that apply.  
￿  Call from the urgent care clinic  
￿  Note, letter, fax, or e-mail from the urgent care 
clinic  
￿  Call from the on-call physician  
￿  Do not usually get notified  
￿  Contact from patient via telephone, e-mail, or 
office visit  
￿  Other, specify: ---------------------------  
  17. For patients you know had an ER visit or were 
hospitalized for an asthma exacerbation, how long after the 
ER visit or hospitalization are you typically notified about a 
patient’s asthma exacerbation? Choose one answer only.  
￿  At time of visit/admission  
￿  A few days later  
￿  Within a month  
￿  Greater than 1 month  
￿  Other, specify: ---------------------------  
  18. For patients you know have visited an urgent care 
clinic for an asthma exacerbation, how long after the urgent 
care visit are you typically notified about a patient’s asthma 
exacerbation? Choose one answer only.  
￿  At time of visit  
￿  A few days later  
￿  Within a month  
￿  Greater than 1 month  
￿  Other, specify: --------------------------  
This Last Section Includes Questions About Treatments 
for Asthma Exacerbations 
  19. How do you typically follow up with patients you 
know have visited the ER or urgent care for an asthma 
exacerbation? Check all that apply.  
￿  Telephone consultation with the patient  
￿  In-office visit  
￿  Other, specify: ---------------------------  
￿  Do not usually follow up unless they want to be 
seen  
  20. How do you typically follow up with patients you 
know have self-treated their asthma exacerbation? Check all 
that apply.  
￿  Telephone consultation with the patient  
￿  In-office visit  14    The Open Respiratory Medicine Journal, 2010, Volume 4  Lincourt et al. 
￿  Other, specify: ----------------------------  
￿  Do not usually follow up unless they want to be seen  
  21. If you are notified that one of your patients has been 
treated for an asthma exacerbation in the ER, how often do 
you require a follow-up visit in your office? Choose one 
answer only.  
￿  All of the time  
￿  Most of the time  
￿  Some of the time  
￿  A little of the time  
  22. If your patient warrants a controller medication, is it 
appropriate for the ER staff to start the patient on the 
controller medication?  
￿  Yes  
￿  No  
  23. If your patient warrants a controller medication, is it 
appropriate for the urgent care staff to start the patient on the 
controller medication?  
￿  Yes 
￿  No 
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